Complementarity of Stenting and Abciximab for Percutaneous Coronary Intervention
Publication
, Journal Article
Kereiakes, D
Published in: Journal of the American College of Cardiology
February 1998
Duke Scholars
Published In
Journal of the American College of Cardiology
DOI
ISSN
0735-1097
Publication Date
February 1998
Volume
31
Issue
2
Start / End Page
54A / 54A
Publisher
Elsevier BV
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Kereiakes, D. (1998). Complementarity of Stenting and Abciximab for Percutaneous Coronary Intervention. Journal of the American College of Cardiology, 31(2), 54A-54A. https://doi.org/10.1016/s0735-1097(97)83943-5
Kereiakes, D. “Complementarity of Stenting and Abciximab for Percutaneous Coronary Intervention.” Journal of the American College of Cardiology 31, no. 2 (February 1998): 54A-54A. https://doi.org/10.1016/s0735-1097(97)83943-5.
Kereiakes D. Complementarity of Stenting and Abciximab for Percutaneous Coronary Intervention. Journal of the American College of Cardiology. 1998 Feb;31(2):54A-54A.
Kereiakes, D. “Complementarity of Stenting and Abciximab for Percutaneous Coronary Intervention.” Journal of the American College of Cardiology, vol. 31, no. 2, Elsevier BV, Feb. 1998, pp. 54A-54A. Crossref, doi:10.1016/s0735-1097(97)83943-5.
Kereiakes D. Complementarity of Stenting and Abciximab for Percutaneous Coronary Intervention. Journal of the American College of Cardiology. Elsevier BV; 1998 Feb;31(2):54A-54A.
Published In
Journal of the American College of Cardiology
DOI
ISSN
0735-1097
Publication Date
February 1998
Volume
31
Issue
2
Start / End Page
54A / 54A
Publisher
Elsevier BV
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology